SPHRY
Price
$0.67
Change
+$0.06 (+9.84%)
Updated
Dec 17 closing price
76 days until earnings call
VACBF
Price
$0.24
Change
-$0.07 (-22.58%)
Updated
Nov 26 closing price
Ad is loading...

SPHRY vs VACBF

Header iconSPHRY vs VACBF Comparison
Open Charts SPHRY vs VACBFBanner chart's image
Starpharma Holdings
Price$0.67
Change+$0.06 (+9.84%)
Volume$550
CapitalizationN/A
NYKODE THERAPEUTICS AS
Price$0.24
Change-$0.07 (-22.58%)
Volume$10.92K
CapitalizationN/A
SPHRY vs VACBF Comparison Chart
Loading...
SPHRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SPHRY vs. VACBF commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SPHRY is a StrongBuy and VACBF is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (SPHRY: $0.67 vs. VACBF: $0.24)
Brand notoriety: SPHRY and VACBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SPHRY: 12% vs. VACBF: 247%
Market capitalization -- SPHRY: $26.66M vs. VACBF: $97.91M
SPHRY [@Biotechnology] is valued at $26.66M. VACBF’s [@Biotechnology] market capitalization is $97.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SPHRY’s FA Score shows that 1 FA rating(s) are green whileVACBF’s FA Score has 1 green FA rating(s).

  • SPHRY’s FA Score: 1 green, 4 red.
  • VACBF’s FA Score: 1 green, 4 red.
According to our system of comparison, both SPHRY and VACBF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SPHRY’s TA Score shows that 3 TA indicator(s) are bullish while VACBF’s TA Score has 1 bullish TA indicator(s).

  • SPHRY’s TA Score: 3 bullish, 4 bearish.
  • VACBF’s TA Score: 1 bullish, 1 bearish.
According to our system of comparison, VACBF is a better buy in the short-term than SPHRY.

Price Growth

SPHRY (@Biotechnology) experienced а -10.96% price change this week, while VACBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

SPHRY is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VACBF($93M) has a higher market cap than SPHRY($25.9M). SPHRY YTD gains are higher at: -46.495 vs. VACBF (-84.759).
SPHRYVACBFSPHRY / VACBF
Capitalization25.9M93M28%
EBITDAN/A-45.34M-
Gain YTD-46.495-84.75955%
P/E RatioN/AN/A-
RevenueN/A6.15M-
Total CashN/A137M-
Total DebtN/A4.79M-
FUNDAMENTALS RATINGS
SPHRY: Fundamental Ratings
SPHRY
OUTLOOK RATING
1..100
89
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SPHRYVACBF
RSI
ODDS (%)
Bullish Trend 2 days ago
65%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
20%
MACD
ODDS (%)
Bearish Trend 2 days ago
73%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
6%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
25%
Advances
ODDS (%)
Bullish Trend 10 days ago
63%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
52%
Bearish Trend 2 days ago
19%
View a ticker or compare two or three
Ad is loading...
SPHRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VACBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IDAI0.420.03
+8.95%
T Stamp
DX12.57-0.14
-1.10%
Dynex Capital
GEN29.38-0.35
-1.18%
Gen Digital
CFFI76.86-1.50
-1.91%
C&F Financial Corp
MCY70.56-2.30
-3.16%
Mercury General Corp

SPHRY and

Correlation & Price change

A.I.dvisor tells us that SPHRY and VACBF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRY and VACBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRY
1D Price
Change %
SPHRY100%
+8.81%
VACBF - SPHRY
29%
Poorly correlated
N/A
TTNP - SPHRY
27%
Poorly correlated
+1.47%
SPHRF - SPHRY
25%
Poorly correlated
-31.11%
ASPHF - SPHRY
22%
Poorly correlated
N/A
INM - SPHRY
21%
Poorly correlated
N/A
More

VACBF and

Correlation & Price change

A.I.dvisor tells us that VACBF and EYEN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VACBF and EYEN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VACBF
1D Price
Change %
VACBF100%
N/A
EYEN - VACBF
32%
Poorly correlated
+7.84%
SPHRY - VACBF
27%
Poorly correlated
+8.81%
RVPH - VACBF
22%
Poorly correlated
-39.13%
ZBIO - VACBF
21%
Poorly correlated
+8.10%
BPTSY - VACBF
20%
Poorly correlated
-16.71%
More